Abbott Integrates Vascular Closure Technology With $65 Mil. Purchase Of IVS
This article was originally published in The Gray Sheet
Executive Summary
Abbott Labs' acquisition of Sunnyvale, Calif.-based Integrated Vascular Systems builds on the larger firm's promise to pursue high-growth medical technology areas following an August spin-off its Hospital Products unit
You may also be interested in...
Abbott Vascular Ripens With Anticipated 2005 Launches Of Stent, Sealant
Rapid hospital discharges associated with Abbott's StarClose will favor the device over manual femoral access closure methods upon launch in the second half of 2005, the firm claims
Abbott Vascular Ripens With Anticipated 2005 Launches Of Stent, Sealant
Rapid hospital discharges associated with Abbott's StarClose will favor the device over manual femoral access closure methods upon launch in the second half of 2005, the firm claims
Abbott StarClose Opens Vascular Closure Options; U.S. Launch Set For 2005
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005